CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE
- 15 May 1976
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 307 (7968), 1044-1047
- https://doi.org/10.1016/s0140-6736(76)92220-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- 1-a-Hydroxyvitamin D3 in Chronic Renal FailureJAMA, 1975
- I alpha-hydroxycholecalciferol: a treatment of renal bone disease.BMJ, 1975
- 1,25-DihydroxycholecalciferolArchives of Internal Medicine, 1974
- ACTION OF 1α-HYDROXY VITAMIN D3 ON CALCIUM ABSORPTION AND BONE RESORPTION IN MANThe Lancet, 1974
- 1,25 Dihydroxy-Vitamin D_3 in Normal Man and Patients with Renal FailureAnnals of Internal Medicine, 1974
- 1-ALPHA-HYDROXYCHOLECALCIFEROL AS A SUBSTITUTE FOR THE KIDNEY HORMONE 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILUREThe Lancet, 1973
- FAILURE OF FORMATION OF 1,25-DIHYDROXYCHOLECALCIFEROL IN CHRONIC RENAL INSUFFICIENCYThe Lancet, 1973
- Vitamin D: A Cholecalciferol Metabolite Highly Active in Promoting Intestinal Calcium TransportScience, 1971
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- A New Oral Isotopic Test of Calcium Absorption *JCI Insight, 1965